Timothy Y Y Lai1, Alvin K H Kwok, Amy W H Au, Dennis S C Lam. 1. Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Eye Hospital, 147 K Argyle Street, Kowloon, Hong Kong, People's Republic of China. tyylai@netvigator.com
Abstract
PURPOSE: To evaluate the changes in macular function and potential retinal toxicity in epiretinal membrane (ERM) surgery with indocyanine green (ICG)-assisted internal limiting membrane (ILM) peeling using multifocal electroretinography (mfERG). METHODS:Thirteen eyes of 13 patients were randomly assigned to have ERM surgery with ILM peeling using 0.5 mg/ml or 1.25 mg/ml ICG staining. Patients were examined at baseline and at 3 and 6 months postoperatively. The postoperative mfERG N1 and P1 response amplitudes and peak latencies of various ring eccentricities were assessed and compared with baseline to determine any serial changes. RESULTS: After surgery, the median best-corrected visual acuity improved from 20/70 at baseline to 20/30 at 6 months postoperatively (Wilcoxon signed-ranks test, P=0.004). At 3 months postoperatively, the 0.5 mg/ml group showed no significant changes in N1 and P1 response amplitudes and peak latencies, whereas the 1.25 mg/ml ICG group showed significant reductions in N1 and P1 response amplitudes compared with baseline. No significant changes in mfERG responses were observed in either group at 6 months after surgery. CONCLUSIONS: Our mfERG findings suggested that the use of a higher concentration of ICG for ILM staining might result in transient retinal functional impairment postoperatively. The lowest possible concentration of ICG should be used intraoperatively to minimize potential retinal toxicity.
RCT Entities:
PURPOSE: To evaluate the changes in macular function and potential retinal toxicity in epiretinal membrane (ERM) surgery with indocyanine green (ICG)-assisted internal limiting membrane (ILM) peeling using multifocal electroretinography (mfERG). METHODS: Thirteen eyes of 13 patients were randomly assigned to have ERM surgery with ILM peeling using 0.5 mg/ml or 1.25 mg/ml ICG staining. Patients were examined at baseline and at 3 and 6 months postoperatively. The postoperative mfERG N1 and P1 response amplitudes and peak latencies of various ring eccentricities were assessed and compared with baseline to determine any serial changes. RESULTS: After surgery, the median best-corrected visual acuity improved from 20/70 at baseline to 20/30 at 6 months postoperatively (Wilcoxon signed-ranks test, P=0.004). At 3 months postoperatively, the 0.5 mg/ml group showed no significant changes in N1 and P1 response amplitudes and peak latencies, whereas the 1.25 mg/ml ICG group showed significant reductions in N1 and P1 response amplitudes compared with baseline. No significant changes in mfERG responses were observed in either group at 6 months after surgery. CONCLUSIONS: Our mfERG findings suggested that the use of a higher concentration of ICG for ILM staining might result in transient retinal functional impairment postoperatively. The lowest possible concentration of ICG should be used intraoperatively to minimize potential retinal toxicity.
Authors: J Hillenkamp; P Saikia; F Gora; H G Sachs; C P Lohmann; J Roider; W Bäumler; V-P Gabel Journal: Br J Ophthalmol Date: 2005-04 Impact factor: 4.638
Authors: L Kodjikian; T Richter; M Halberstadt; F Beby; F Flueckiger; M Boehnke; J G Garweg Journal: Graefes Arch Clin Exp Ophthalmol Date: 2005-04-15 Impact factor: 3.117
Authors: Timothy L Jackson; Jost Hillenkamp; Bruce C Knight; Jin-Jun Zhang; Dhanes Thomas; Miles R Stanford; John Marshall Journal: Invest Ophthalmol Vis Sci Date: 2004-08 Impact factor: 4.799
Authors: Donald W Park; Pravin U Dugel; Jennifer Garda; Jack O Sipperley; Allen Thach; Scott R Sneed; Jennifer Blaisdell Journal: Ophthalmology Date: 2003-01 Impact factor: 12.079
Authors: Chryssanthi N Koutsandrea; Michael N Apostolopoulos; Dimitrios A Alonistiotis; Marilita M Moschos; Efstratia Georgiadou; Theodora E Kyriaki; Gerasimos T Georgopoulos; Michael N Moschos Journal: Clin Ophthalmol Date: 2007-12
Authors: Wojciech Lubiński; Wojciech Gosławski; Karol Krzystolik; Maciej Mularczyk; Leszek Kuprjanowicz; Michał Post Journal: Doc Ophthalmol Date: 2016-04-28 Impact factor: 2.379